Fennec Pharmaceuticals (FENC) Change in Receivables (2023 - 2025)

Fennec Pharmaceuticals (FENC) has 3 years of Change in Receivables data on file, last reported at $3.5 million in Q4 2025.

• Quarterly Change in Receivables rose 1876.0% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.4 million (up 58.01% YoY) and the FY2025 annual result came in at $12.4 million, up 58.01% from the prior year.
• Change in Receivables climbed to $3.5 million in Q4 2025, from $3.4 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $5.3 million in Q1 2025 to a low of $138000.0 in Q1 2023.
• A 3-year average of $2.3 million and a median of $2.1 million in 2023 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2024 — Change in Receivables tumbled 95.92% — and 2025, when it soared 1876.0%.
• Tracing FENC's Change in Receivables over 3 years: stood at $4.3 million in 2023, then plunged by 95.92% to $175000.0 in 2024, then soared by 1876.0% to $3.5 million in 2025.
• The last three Change in Receivables figures came in at $3.5 million (Q4 2025), $3.4 million (Q3 2025), and $265000.0 (Q2 2025), per Business Quant data.